Jinghan Su
- Biomedical Engineering top 1%
- Biomaterials top 0.5%
- Molecular Biology top 10%
- Materials Chemistry
- Immunology top 10%
- Topics
- Nanoparticle-Based Drug Delivery (14 papers)Nanoplatforms for cancer theranostics (14 papers)Advanced biosensing and bioanalysis techniques (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jinghan Su
20 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Biomedical Engineering 1.7k
- Biomaterials 1.2k
- Molecular Biology 981
- Materials Chemistry 323
- Immunology 236
Countries citing papers authored by Jinghan Su
This map shows the geographic impact of Jinghan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinghan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinghan Su more than expected).
Fields of papers citing papers by Jinghan Su
This network shows the impact of papers produced by Jinghan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinghan Su. The network helps show where Jinghan Su may publish in the future.
Co-authorship network of co-authors of Jinghan Su
This figure shows the co-authorship network connecting the top 25 collaborators of Jinghan Su. A scholar is included among the top collaborators of Jinghan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinghan Su. Jinghan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 16 | |
| 7 | 78 | |
| 8 | 267 | |
| 9 | 182 | |
| 10 | 9 | |
| 11 | 98 | |
| 12 | 32 | |
| 13 | 204 | |
| 14 | Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumorsbreakdown → | 540 |
| 15 | 154 | |
| 16 | 318 | |
| 17 | 87 | |
| 18 | 128 | |
| 19 | 26 | |
| 20 | 67 |
About Jinghan Su
Jinghan Su is a scholar working on Biomaterials, Biomedical Engineering and Oncology, having authored 20 papers that have together received 2.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), Nanoplatforms for cancer theranostics (14 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Biomaterials (1.2k citations), Biomedical Engineering (1.7k citations) and Molecular Biology (981 citations). Jinghan Su has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yaping Li, Pengcheng Zhang, Qi Yin, Qingshuo Meng, Haijun Yu, Huiping Sun, Zhiwen Zhang, Wangwen Gu, Lingli Chen and Siling Wang. Their work appears in journals such as Advanced Materials, Biomaterials and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.